Arvee Laboratories IPO is a fixed price issue of ₹8.91 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹8.91 crore.
Arvee Laboratories IPO bidding started from Feb 9, 2018 and ended on Feb 14, 2018. The shares got listed on NSE SME on Feb 22, 2018.
Arvee Laboratories IPO price is ₹61.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,22,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,44,000.
Sarthi Capital Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Wealth First Portfolio Managers Pvt.Ltd..
Refer to Arvee Laboratories IPO RHP for detailed Information.
IPO Date | February 9, 2018 to February 14, 2018 |
Listing Date | February 22, 2018 |
Face Value | ₹10 per share |
Issue Price Band | |
Issue Price Final | ₹61 per share |
Lot Size | 2,000 Shares |
Sale Type | Fresh Capital |
Total Issue Size | 14,60,000 shares (aggregating up to ₹8.91 Cr) |
Reserved for Market Maker | 76,000 shares Wealth First Portfolio Managers Pvt.Ltd. (aggregating up to ₹0.4636 Cr) |
Net Offered to Public | 13,84,000 shares (aggregating up to ₹8.44 Cr) |
Issue Type | Fixed Price IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 40,50,000 shares |
Share Holding Post Issue | 55,10,000 shares |
Arvee Labs IPO offers total 14,60,000 shares. Out of which 6,92,000 (47.40%) allocated to NII, 6,92,000 (47.40%) allocated to RII.
Investor Category | Shares Offered |
---|---|
Market Maker Shares Offered | 76,000 (5.21%) |
NII (HNI) Shares Offered | 6,92,000 (47.40%) |
Retail Shares Offered | 6,92,000 (47.40%) |
Total Shares Offered | 14,60,000 (100.00%) |
Arvee Laboratories IPO opens on February 9, 2018, and closes on February 14, 2018.
IPO Open Date | Fri, Feb 9, 2018 |
IPO Close Date | Wed, Feb 14, 2018 |
Tentative Listing Date | Thu, Feb 22, 2018 |
Cut-off time for UPI mandate confirmation | 5 PM on Wed, Feb 14, 2018 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 2,000 | ₹1,22,000 |
Retail (Max) | 1 | 2,000 | ₹1,22,000 |
HNI (Min) | 2 | 4,000 | ₹2,44,000 |
Incorporated in 2012, Arvee Laboratories (India) Limited is Ahmadabad, Gujarat based company engaged in trading in specialty chemicals by getting manufacturing done on job work basis. Company has plans to begin manufacturing of specialty chemicals in near future.
Arvee Labs is mainly engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. Company caters to the demand of both domestic as well as international markets.
Arvee Labs bought land, building and machineries from Skylink Chemicals Private Limited who was engaged in manufacturing of specialty chemicals. Currently, Company is negotiating with IDBI Bank Limited to take over the business of Skylead Chemicals Limited which has been declared as sick by BIFR.
Particulars | For the year/period ended (in Rs. million) | |||||
---|---|---|---|---|---|---|
31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
Total Assets | 356.75 | 352.10 | 260.29 | 174.22 | 89.07 | |
Total Revenue | 349.37 | 269.24 | 130.52 | 118.36 | 35.59 | |
Profit After Tax | 15.52 | 1.87 | (16.47) | 0.19 | 0.43 |
The Company Arvee Laboratories IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
---|---|---|
1 | Re-payment of Unsecured Loans of Promoters | 8.41 |
2 | Issue Expenses | 0.50 |
[Dilip Davda] <p>Considering aggressive pricing and average but inconsistant performance so far, one may give this issue a miss.</p> Read detail review...
Listing Date | February 22, 2018 |
BSE Script Code | |
NSE Symbol | ARVEE |
ISIN | INE006Z01016 |
Final Issue Price | ₹61 per share |
Price Details | NSE SME |
---|---|
Final Issue Price | ₹61.00 |
Open | ₹60.95 |
Low | ₹60.50 |
High | ₹66.50 |
Last Trade | ₹62.50 |
Arvee Laboratories (India) Ltd.
4th Floor, Anison Buliding, Stadium Five Roads,
Swastik Society, Opp. Shreyas Hospital,
Navrangapura,
Ahmedabad, Gujarat, 380009
Phone: +91-79-26749036/37/38
Email: shalin.patel@arveelabs.com
Website: http://arveelabs.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Arvee Laboratories IPO is a SME IPO of 14,60,000 equity shares of the face value of ₹10 aggregating up to ₹8.91 Crores. The issue is priced at ₹61 per share. The minimum order quantity is 2000.
The IPO opens on February 9, 2018, and closes on February 14, 2018.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Arvee Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Arvee Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Arvee Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Arvee Laboratories IPO opens on February 9, 2018 and closes on February 14, 2018.
Arvee Laboratories IPO lot size is 2000, and the minimum amount required for application is ₹1,22,000.
You can apply in Arvee Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Arvee Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Arvee Laboratories IPO allotment status.
The Arvee Laboratories IPO listing date is on Thursday, February 22, 2018.
Useful Articles